Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of Annual Report and Notice of AGM

1 Feb 2019 07:00

RNS Number : 7584O
MXC Capital Limited
01 February 2019
 

 

 

MXC Capital Limited

("MXC" or the "Company")

 

Posting of Annual Report, Notice of AGM, Board Changes and

Proposed Share Consolidation

 

MXC (AIM: MXCP), the technology focused adviser and investor, announces that its Annual Report and Accounts for the year ended 31 August 2018, together with the Notice of the Annual General Meeting ("AGM") and a Form of Proxy, are today being posted to shareholders. The documents are available to download from the Company's website www.mxccapital.com.

The AGM is to be held on 14 February 2019 at 12.00 noon at 1st Floor, Elizabeth House, Les Ruettes Brayes, St Peter Port, Guernsey, GY1 1EW. 

Board Changes

The Company also announces that Meriel Lenfestey has notified the Board of her intention to not seek re-election at this time and will therefore step down from her position as Non-Executive Director at the upcoming AGM. The Board would like to thank Meriel for her contribution during her tenure as a director. It is the intention to recruit a new independent non-executive director in due course to strengthen the Board.

Proposed Share Consolidation

Contained within the Notice of AGM is a letter to shareholders describing proposals for a share capital consolidation (the "Consolidation"), and the resolution required to effect this will be put to shareholders at the forthcoming AGM as an ordinary resolution.

As at 29 January 2019, the Company had 3,360,167,484 ordinary shares of no par value ("Existing Ordinary Shares") in issue. The Directors consider that it is in the best interests of the Company as a public quoted company to have a more manageable number of issued ordinary shares and to have a higher share price.

Accordingly, it is proposed that the Company's share capital be reorganised such that every 50 Existing Ordinary Shares be consolidated into 1 new ordinary share of no par value ("New Ordinary Shares").

 

As all of the Existing Ordinary Shares are proposed to be consolidated, the proportion of issued ordinary share holdings in the Company held by each shareholder immediately before and immediately after the Consolidation will, save for fractional entitlements (the treatment of which is described below), remain unchanged.

 

Fractional entitlements

 

It is likely that the Consolidation will result in fractional entitlements to a New Ordinary Share where any holding is not precisely divisible by 50. No certificates will be issued for fractional entitlements to New Ordinary Shares. Following the implementation of the Consolidation, certain shareholders may not have a proportionate shareholding of New Ordinary Shares exactly equal to their proportionate holding of Existing Ordinary Shares. Furthermore, any shareholders holding fewer than 50 Existing Ordinary Shares as at close of business on 14 February 2019 will cease to be a shareholder of the Company. The minimum threshold to receive New Ordinary Shares will be 50 Existing Ordinary Shares. The articles of association currently permit the Directors to sell shares representing fractional entitlements arising from the proposed consolidation. Any New Ordinary Shares in respect of which there are fractional entitlements will therefore be aggregated and sold in the market for the best price reasonably obtainable on behalf of shareholders entitled to fractions. The Company will distribute the proceeds of sale in due proportion to any such shareholders subject to the minimum threshold referred to in the next paragraph.

 

 

In the event that the net proceeds of sale to be distributed to any relevant shareholder amount to £2 or less, the Directors are of the view that, as a result of the administrative burden and disproportionate costs involved, it would not be in the best interests of the Company to distribute such proceeds of sale. Accordingly, the Directors are proposing that the net proceeds arising from the sale of fractions need only be distributed to a shareholder where he or she is entitled to receive more than £2 (and, below that minimum threshold, it is proposed that the proceeds of sale be donated to charity).

 

Given the current share price per Existing Ordinary Share, it is anticipated that the net proceeds of sale attributable to each relevant shareholder will be less than £2 and, accordingly, there will be no distribution of any net proceeds of sale. For the avoidance of doubt, the Company is only responsible for dealing with fractions arising on registered holdings. For shareholders whose shares are held in the nominee accounts of UK stockbrokers, the effect of the Consolidation on their individual shareholdings will be administered by the stockbroker or nominee in whose account the relevant shares are held. The effect is expected to be the same as for shareholdings registered in beneficial names, however, it is the responsibility of the stockbroker or nominee to deal with fractions arising within their customer accounts, and not the responsibility of the Company.

 

Resulting share capital

 

If approved by shareholders, the issued share capital of the Company immediately following the consolidation is expected to comprise 67,203,349 New Ordinary Shares (assuming that no other shares are allotted and issued by the Company between the date of this document and the AGM).

 

Admission of the New Ordinary Shares

 

Application will be made for the New Ordinary Shares to be admitted to trading on AIM in place of the Existing Ordinary Shares.

 

It is expected that Admission will become effective and that dealings in the New Ordinary Shares will commence on 15 February 2019. Following the Consolidation, the Company's new ISIN Code will be GG00BGK3LD00 and its new SEDOL Code will be BGK3LD0.

 

Rights attaching to New Ordinary Shares

 

The New Ordinary Shares arising upon implementation of the consolidation will have the same rights as the Existing Ordinary Shares including voting, dividend, return of capital and other rights.

 

Effects on Options, Warrants and Other Instruments

 

The entitlements to Ordinary Shares of holders of securities or instruments convertible into ordinary shares (such as share options and warrants) are expected to be adjusted to reflect the Consolidation.

 

Expected Timetable for Consolidation

Notice of AGM posted to Shareholders

1 February 2019

Latest time and date for receipt of Forms of Proxy

12 noon on 12 February 2019

Annual general meeting

12 noon on 14 February 2019

Record date for Consolidation

5.00 p.m. on 14 February 2019

Existing Ordinary Shares disabled in CREST and share register closed

5.00 p.m. on 14 February 2019

Expected date on which New Ordinary Shares admitted to AIM

8.00 a.m. on 15 February 2019

Expected date on which CREST accounts are to be credited

15 February 2019

Expected date by which definitive new share certificates are to be despatched

1 March 2019

ISIN of New Ordinary Shares

GG00BGK3LD00

 

MXC Capital Limited

Ian Smith

+44(0)20 7965 8149

Zeus Capital Limited (Nominated adviser and broker)

Nick How

+44 (0)20 3829 5000

About MXC Capital Limited www.mxccapital.com

MXC is a specialist technology adviser and investor with a track record of investing in and advising companies in the TMT sector. MXC brings together a deep knowledge of technology, first-hand experience of managing companies in the sector, an ability to make meaningful investments and a highly experienced corporate advisory team in support, all of which combine to grow shareholder value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAUAORRKVAAOUR
Date   Source Headline
19th May 20172:34 pmRNSTransaction in Own Shares / Total Voting Rights
16th May 20171:40 pmRNSTransaction in Own Shares / Total Voting Rights
15th May 201711:46 amRNSTransaction in Own Shares / Total Voting Rights
12th May 201712:08 pmRNSTransaction in Own Shares/ Total Voting Rights
11th May 201712:35 pmRNSTransaction in Own Shares/ Total Voting Rights
11th May 20179:52 amRNSTransaction in Own Shares/ Total Voting Rights
10th May 20177:26 amRNSInterim Results
5th May 20177:16 amRNSTransaction in Own Shares / Total Voting Rights
3rd Apr 20177:00 amRNSExtension of Share Buyback Programme
29th Mar 20173:18 pmRNSTransaction in Own Shares / Total Voting Rights
28th Mar 201711:50 amRNSTransaction in Own Shares / Total Voting Rights
27th Mar 20174:19 pmRNSTransaction in Own Shares / Total Voting Rights
24th Mar 20174:44 pmRNSTransaction in Own Shares/ Total Voting Rights
22nd Mar 201711:16 amRNSTransaction in Own Shares / Total Voting Rights
21st Mar 20176:29 pmRNSTransaction in Own Shares / Total Voting Rights
20th Mar 20172:20 pmRNSTransaction in Own Shares / Total Voting Rights
20th Mar 201711:08 amRNSTransaction in Own Shares / Total Voting Rights
17th Mar 20176:17 pmRNSTransaction in Own Shares / Total Voting Rights
16th Mar 201710:24 amRNSTransaction in Own Shares / Total Voting Rights
15th Mar 20179:18 amRNSTransaction in Own Shares / Total Voting Rights
14th Mar 201710:17 amRNSTransaction in Own Shares / Total Voting Rights
13th Mar 201711:04 amRNSTransaction in Own Shares / Total Voting Rights
10th Mar 20171:23 pmRNSTransaction in Own Shares / Total Voting Rights
10th Mar 201710:48 amRNSTransaction in Own Shares / Total Voting Rights
9th Mar 201710:11 amRNSTransaction in Own Shares / Total Voting Rights
9th Mar 20177:00 amRNSTrading Update
8th Mar 20177:00 amRNSIssue of Equity / Total Voting Rights
3rd Mar 20173:12 pmRNSSale of Redcentric Shares
3rd Mar 201710:47 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
3rd Mar 201710:06 amRNSSale of Redcentric Shares
2nd Mar 20179:39 amRNSTransaction in Own Shares / Total Voting Rights
1st Mar 20174:43 pmRNSTransaction in Own Shares / Total Voting Rights
1st Mar 201710:00 amRNSSale of Redcentric Shares
24th Feb 20172:31 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Feb 201710:33 amRNSTransaction in Own Shares / Total Voting Rights
22nd Feb 201711:50 amRNSTransaction in Own Shares / Total Voting Rights
6th Feb 20173:22 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
6th Feb 20172:00 pmRNSSale of Redcentric Shares
26th Jan 20172:39 pmRNSResult of AGM
26th Jan 20172:18 pmRNSNotice of AGM
23rd Jan 20177:00 amRNSExercise of Redcentric Options
10th Jan 20179:42 amRNSPosting of Annual Report and Accounts
6th Jan 20174:30 pmRNSTransaction in Own Shares
5th Jan 20173:57 pmRNSTransaction in Own Shares
3rd Jan 20171:34 pmRNSTransaction in Own Shares
23rd Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 201611:16 amRNSTransaction in Own Shares
22nd Dec 20169:14 amRNSShare Buyback Programme
1st Dec 20167:00 amRNSFinal Results
23rd Nov 20167:00 amRNSResignation as Financial Adviser to Redcentric

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.